Cargando…

MEDB-27. Clinico-Radiological Outcomes in WNT-pathway Medulloblastoma: Retrospective Single Institutional Audit

BACKGROUND: Medulloblastoma (MB) is a heterogeneous disease comprising 4 molecular subgroups - wingless (WNT), sonic hedgehog, Group 3, and Group 4 tumors - with distinct developmental origins, diverse clinico-demographic characteristics, unique transcriptional profiles, and widely varying outcomes....

Descripción completa

Detalles Bibliográficos
Autores principales:	Mani, Shakthivel, Chatterjee, Abhishek, Sridhar, Epari, Sahay, Ayushi, Shirsat, Neelam, Moiyadi, Aliasgar, Shetty, Prakash, Chinnaswamy, Girish, Patil, Vijay, Dasgupta, Archya, Bano, Nazia, Gupta, Tejpal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Medulloblastoma
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165174/ http://dx.doi.org/10.1093/neuonc/noac079.401

Ejemplares similares

WNT-pathway medulloblastoma: what constitutes low-risk and how low can one go?
por: Mani, Shakthivel, et al.
Publicado: (2023)

MBRS-61. MOLECULAR SUB-GROUPING OF PEDIATRIC MEDULLOBLASTOMA: CORRELATION WITH CLINICAL AND HISTOLOGICAL FEATURES, A SINGLE INSTITUTIONAL STUDY
por: Deshpande, Gauri, et al.
Publicado: (2020)

EMBR-17. DE-INTENSIFICATION OF RADIOTHERAPY IN RIGOROUSLY DEFINED LOW-RISK WNT-SUBGROUP MEDULLOBLASTOMA IS ASSOCIATED WITH UNACCEPTABLY HIGH RISK OF NEURAXIAL FAILURE: RESULTS FROM THE PROSPECTIVE FOR-WNT STUDY
por: Gupta, Tejpal, et al.
Publicado: (2021)

MEDB-33. The landscape of ecDNA in medulloblastoma
por: Chapman, Owen, et al.
Publicado: (2022)

MEDB-86. A re-induction regimen for children with recurrent medulloblastoma
por: O'Halloran, Katrina, et al.
Publicado: (2022)

MEDB-66. Investigating intra-tumoral heterogeneity of extrachromosomal DNA in SHH medulloblastoma
por: Chapman, Owen, et al.
Publicado: (2022)

MEDB-31. THE CLINICAL SIGNIFICANCE OF EXTENT OF RESECTION IN MEDULLOBLASTOMA
por: Keeling, Claire, et al.
Publicado: (2022)

EMBR-14. INFLUENCE OF MRI FEATURES ON THE SURVIVAL AND IMPACT ON INDIVIDUAL MOLECULAR SUBGROUPS: RESULT FROM 171 PATIENTS WITH MEDULLOBLASTOMA
por: Dasgupta, Archya, et al.
Publicado: (2021)

MEDB-44. Transcriptomic resolution of subgroup-specific medulloblastoma architecture
por: Willard, Nicholas, et al.
Publicado: (2022)

MEDB-72. MOLECULAR CHARACTERIZATION OF MEDULLOBLASTOMAS IN A SINGLE INSTITUTION
por: Tan, Enrica E K, et al.
Publicado: (2022)

MEDB-23. Targeting epigenetic dysregulation in medulloblastoma with poor prognosis
por: Badodi, Sara, et al.
Publicado: (2022)

MEDB-10. Comparing pediatric medulloblastoma with and without spinal metastasis
por: Tang, Phua Hwee, et al.
Publicado: (2022)

MEDB-21. SOX2(+) cells: the perpetrators of medulloblastoma relapse
por: Swiderska-Syn, Marzena, et al.
Publicado: (2022)

MEDB-64. Are Rab GTPases metastatic drivers in metastatic medulloblastoma?
por: Entwistle, Susannah, et al.
Publicado: (2022)

MEDB-67. Subgroup specific analysis of cellular metabolism in medulloblastoma
por: Funke, Viktoria, et al.
Publicado: (2022)

MEDB-84. The French experience of ELP1-related medulloblastomas
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2022)

MEDB-39. Oncogenic mechanisms underlying GLI2-amplified medulloblastoma
por: Murad, Najiba, et al.
Publicado: (2022)

MEDB-47. CD4+ T cells restrict medulloblastoma growth and dissemination
por: Eisemann, Tanja, et al.
Publicado: (2022)

MEDB-80. CDK8 promotes stemness of MYC-driven medulloblastoma
por: Wang, Dong, et al.
Publicado: (2022)

MEDB-76. Evaluating the B7-H3 checkpoint in Medulloblastoma
por: Moziak, Kirsten, et al.
Publicado: (2022)

MEDB-87. Transcriptome-driven drug repurposing in group 3 medulloblastoma
por: Doss, David, et al.
Publicado: (2022)

MEDB-58. Risk factors and risk prediction models for medulloblastoma recurrence
por: Li, Juan, et al.
Publicado: (2022)

MEDB-70. Metabolism mediated radiation resistance in MYC-driven Medulloblastoma
por: Veo, Bethany, et al.
Publicado: (2022)

MEDB-63. Deciphering the role of LIN28B in Group 3 medulloblastoma
por: Shahab, Shubin, et al.
Publicado: (2022)

MEDB-57.GNAS inactivation as a driver for sonic hedgehog-activated medulloblastoma
por: Goode, Erin, et al.
Publicado: (2022)

MEDB-48. Infant medulloblastoma - SHH subtype – with residual disease. To treat or not to treat
por: Dahl, Christine, et al.
Publicado: (2022)

MEDB-32. Reducing treatment-related toxicity for children with WNT-activated medulloblastoma
por: Taylor, Jessica, et al.
Publicado: (2022)

MEDB-14. Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome
por: Kolodziejczak, Anna, et al.
Publicado: (2022)

MEDB-54. Standard Risk Medulloblastoma treated solely with surgery and chemo-radiation
por: Cantor, Evan, et al.
Publicado: (2022)

MEDB-83. A novel epigenetic nanotherapeutic strategy to induce medulloblastoma differentiation
por: Raju, Praveen, et al.
Publicado: (2022)

MEDB-74. Serial assessment of measurable residual disease in medulloblastoma liquid biopsies
por: Northcott, Paul, et al.
Publicado: (2022)

MEDB-59. A draft atlas of medulloblastoma cellular evolution under therapy
por: Wang, Lin, et al.
Publicado: (2022)

MEDB-36. Clinical and molecular heterogeneity withinMYC andMYCN amplified medulloblastoma
por: Schwalbe, Edward, et al.
Publicado: (2022)

MEDB-78. Unified rhombic lip origins of Group 3 and Group 4 medulloblastoma
por: Smith, Kyle, et al.
Publicado: (2022)

MEDB-73. Lipid metabolism as a therapeutic vulnerability in BET inhibitor-resistant medulloblastoma
por: Lupien, Leslie, et al.
Publicado: (2022)

MEDB-20. The outcome of medulloblastoma patients in the 2010-2018 period in Children’s Hospital Zagreb
por: Jadrijevic-Cvrlje, Filip, et al.
Publicado: (2022)

MEDB-09. Unraveling the role of unfolded protein response in medulloblastoma cancer stem cells
por: Spinello, Zaira, et al.
Publicado: (2022)

MEDB-37. Chemotherapy response prediction by molecular risk factors in metastatic childhood medulloblastoma
por: Obrecht, Denise, et al.
Publicado: (2022)

MEDB-82. Exploring cell-cell communication networks in medulloblastoma using single-cell genomics
por: Gabler, Lisa, et al.
Publicado: (2022)

MEDB-51. Impact of residual tumor on outcomes in children and adolescents with medulloblastoma in the German HIT-cohort
por: Wolgast, Stella, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_32cnbobe9g7gpp30760etke1ku